Conexeu Sciences Inc. Common Stock
CNXUStock
$10.51
Market Cap—
P/E—
Div yield—
Beta-4.14
Price Chart
Favorite Metrics
Price vs S&P 500 (4W)-2.86%
VGM Score18.81
Industry Peers — Orthopedic & Prosthetic Devices(33)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
CNXUConexeu Sciences Inc. Common Stock | — | — | F | $10.51 |
| ISRGIntuitive Surgical Inc. | D | B | D | $402.33 |
| EWEdwards Lifesciences Corp | D | C | B | $87.84 |
| STESTERIS plc | B | B | C | $221.13 |
| ZBHZimmer Biomet Holdings, Inc. | B | C | C | $93.75 |
| ALGNAlign Technology Inc | C | C | C | $178.41 |
| SNNSmith & Nephew plc | B | C | C | $31.41 |
| MSAMine Safety Incorporated | C | C | C | $173.39 |
| ESTAEstablishment Labs Holdings Inc. | F | A | A | $92.30 |
| ENOVEnovis Corporation | B | D | C | $28.07 |
| CDRECadre Holdings, Inc. | B | C | D | $30.18 |
About
Conexeu Sciences Inc is an early-stage medical technology company. The company develops and supplies collagen-based technologies that helps doctors and patients regenerate tissue naturally, safely, and effectively. The company is focused on developing regenerative biomaterials that address relative needs in wound care, dentistry, and aesthetics. The company seek to provide physicians with device-based solutions that improve healing, restore soft tissue, and enhance patient outcomes across multiple clinical settings. The company focuses durable, and growing addressable markets in regenerative aesthetics, wound care, 3D-printed tissue structures, veterinary wound repair, and dental soft-tissue regeneration.